Dublin, Jan. 17, 2019 (GLOBE NEWSWIRE) -- The "US Drug Prices Plan Database" newsletter has been added to ResearchAndMarkets.com's offering.
The US Drug Prices Plan Database helps drug companies make better decisions through the delivery of cutting-edge business intelligence. The US Drug Prices plan is focused on the interests of drug manufacturers, suppliers, distributors, and payers.
The features of the US Drug Prices plan include:
- Brand vs. Generic Drug Price
- Average Pharmacy Cost
- Best-Available Price
The researcher is provider of global business intelligence on biologic and small-molecule drugs, dedicated to helping clients make better decisions. Critical information on global drug patents is incorporated with litigation intelligence, drug prices, and historic sales figures to help users discover commercial opportunities and forecast future revenue events. Since 2005 the researcher has served hundreds of large and small companies in more than 65 countries.
Key Topics Covered:
- Brand vs. Generic Drug Price
- Average Pharmacy Cost
- Best-Available Price
For more information about this newsletter visit https://www.researchandmarkets.com/research/59d95k/united_states?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.